PHOTO
Abu Dhabi: Abu Dhabi University (ADU) and Abu Dhabi Stem Cells Center (ADSCC) signed a Memorandum of Understanding (MoU) that aims to promote ties between both institutions through student placements, training programs, sharing facilities and resources, and exchanging academic information in the field of medicine.
Professor Waqar Ahmad, the Chancellor of Abu Dhabi University and Dr Yendry Ventura, Specialist in Immunology and General Manager of the Abu Dhabi Stem Cells Center attended the MoU signing, which took place virtually. Under the agreement, ADU and ADSCC will establish cooperative relations that will enhance educational and outreach opportunities for their students and faculty. As part of the collaboration, ADU students were offered hands-on training in molecular biology and basic immunology.
The MoU includes the exchange of advanced educational expertise through training workshops, conferences, and academic programs that will provide the latest developments and best practices. In addition, ADU will have access to the ADSCC’s medical diagnostic laboratories and ADU’s students and faculty will be offered a wider perspective in the field of diagnostic medicine, nutrition technology and dietetics.
Commenting on the agreement, Prof. Wassim Y. Almawi, Dean of College of Health Sciences at Abu Dhabi University, said, “We are honored to enter this strategic partnership with one of the most advanced healthcare centers in the UAE, as it will allow us to accelerate our vision of providing a holistic learning experience to our community. ADU takes pride in arming its students with the knowledge needed to become professionals in their respective fields; and with the support of Abu Dhabi Stem Cells Center and the crucial training opportunities offered, I am confident that our students will realize their full potential and meet the healthcare needs of the UAE.”
He continued, “We are constantly seeking local and international partnerships with like-minded institutions that would allow us to provide ‘out of the box’ solutions and achieve our promise of creating a healthier community in the UAE.”
Dr Yendry Ventura from ADSCC, said “Our ambition, from the start, has been to strengthen home-grown medical research capabilities to address the most urgent chronic diseases in the country. We cannot truly realize this ambition without creating growth opportunities for local and regional medical students. We are proud to forge this partnership with a highly regarded institution like Abu Dhabi University as we shape our next generation of doctors and researchers, and we look forward to undertaking truly groundbreaking work together.”
Founded in 2019 as a first-of-its-kind specialist healthcare center in the United Arab Emirates, ADSCC is focused on cellular and regenerative medicine, such as stem cell therapy research. It is uniquely set up to conduct complex research and was among the first worldwide to conduct research for a patented COVID-19 treatment. It aims to meet the growing domestic and regional demand for highly specialized medical services and treatments by harnessing the latest technologies, medical devices which are unique to the region, and a team of internationally recognized doctors working hand in hand with researchers.
ADU’s College of Health Sciences focuses on providing high-quality education in public health, environmental health and safety, nutrition, and biomedical sciences. It aims to offer advanced research opportunities for its students and to proactively engage with and contribute to the communities in which they live and work in.
To learn more about the College of Health Sciences at ADU, please visit www.adu.ac.ae
-Ends-
About Abu Dhabi University:
Established in 2003, Abu Dhabi University (ADU) is the largest private university in the United Arab Emirates. With campuses across Abu Dhabi, Dubai, Al Ain, and Al Dhafra, the University has a total enrolment of 7,800 students from over 80 nationalities. Structured into Colleges of Arts and Sciences, Business, Engineering, Law and Health Sciences, ADU offers undergraduate and graduate programs across a wide range of disciplines.
Abu Dhabi University is recognized as a world-class institution committed to excellence in teaching, research and student experience, as evidenced by its prestigious regional and international accreditations. The University was the first private higher education institution in the GCC to earn international accreditation from the Californian Western Association of Schools and Colleges (WASC). ADU’s College of Business is accredited by the Association to Advance Collegiate Schools of Business (AACSB) and the prestigious EFMD Quality Improvement System (EQUIS). At a program level, the College of Engineering has received international accreditation from the world-renowned Accreditation Board for Engineering and Technology (ABET), and the Bachelor of Architecture has received Part 1 validation from the Royal Institute of British Architects (RIBA). The College of Health Sciences has earned accreditation from the Agency for Public Health Education Accreditation (APHEA).
According to the 2021 QS World University rankings, Abu Dhabi University ranked among the top 750 universities in the world and placed among the world’s top 150 universities under 50 years of age. ADU also earned a top 3 spot globally for international faculty and maintained its long-held position as part of the top 11 universities worldwide recognized for student body diversity.
About Abu Dhabi Stem Cells Center (ADSCC)
The first-of-its kind in the Emirate of Abu Dhabi, Abu Dhabi Stem Cells Center (ADSCC), affiliated with the Yas Clinic Group, is an Abu Dhabi-based specialist healthcare center focused on cell therapy and regenerative medicine techniques, as well as delivering cutting-edge research on stem cell therapy in the region.
The Center was founded in March 2019 to meet growing domestic and regional demand for highly specialized medical services and treatments. ADSCC is equipped with the latest technologies, medical devices which are unique to the region, and a team of internationally recognized doctors who work hand-in-hand with researchers.
Specialties include immunology, hematology, clinical stem cell therapy, molecular biology, orthopedics, and urology, amongst others.
The Center primarily focuses on harvesting, processing, characterizing, and storing cell products for clinical application in both regenerative medicine and hematopoietic transplantation. It aims to streamline and develop new processes related to stem cell therapy and research, to both serve the team of doctors’ clinical needs and become a referral center for the region.
In 2020, ADSCC became a fundamental resource for Abu Dhabi in the fight against COVID-19. ADSCC has been instrumental in providing COVID-19 swab tests to the residents of Abu Dhabi and continue to process almost 9% of the total UAE samples daily. Its Mushrif laboratory is a purpose-built COVID-19 lab, sampling swabs daily.
Media Contacts
Weber Shandwick for Abu Dhabi University
Mohammad Al Azzam
malazzam@webershandwick.com
+971 2 449 4457
H&K Strategies for Abu Dhabi Stem Cells Center
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
